Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M366Revenue $M70.6Net Margin (%)0.6Altman Z-Score-2.2
Enterprise Value $M315EPS $-0.0Operating Margin %-10.0Piotroski F-Score6
P/E(ttm)36.4Beneish M-Score-2.7Pre-tax Margin (%)0.6Higher ROA y-yY
Price/Book63.810-y EBITDA Growth Rate %--Quick Ratio3.7Cash flow > EarningsN
Price/Sales5.35-y EBITDA Growth Rate %--Current Ratio3.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)0.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)1.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M143ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with ARRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARRYKen Fisher 2015-09-30 Buy $4.56 - $7.11
($5.94)
$ 2.55-57%New holding135,695
ARRYFirst Eagle Investment 2011-12-31 Sold Out -0.0024%$1.77 - $2.83
($2.28)
$ 2.5512%Sold Out0
ARRYGeorge Soros 2011-12-31 Sold Out -0.0008%$1.77 - $2.83
($2.28)
$ 2.5512%Sold Out0
ARRYGeorge Soros 2011-09-30 Buy $1.99 - $2.62
($2.24)
$ 2.5514%New holding22,400
ARRYFirst Eagle Investment 2011-06-30 Add$2.06 - $3.21
($2.7)
$ 2.55-6%Add 150.00%250,000
ARRYGeorge Soros 2011-06-30 Sold Out $2.06 - $3.21
($2.7)
$ 2.55-6%Sold Out0
ARRYFirst Eagle Investment 2011-03-31 Buy $2.7 - $3.29
($3)
$ 2.55-15%New holding100,000
ARRYGeorge Soros 2011-03-31 Buy $2.7 - $3.29
($3)
$ 2.55-15%New holding14,400
ARRYFirst Eagle Investment 2010-09-30 Sold Out -0.01%$2.67 - $3.44
($3.02)
$ 2.55-16%Sold Out0
ARRYFirst Eagle Investment 2010-06-30 Reduce-0.01%$2.66 - $4.02
($3.41)
$ 2.55-25%Reduce -54.96%450,000
ARRYFirst Eagle Investment 2009-12-31 Add0.01%$1.72 - $2.81
($2.2)
$ 2.5516%Add 62.96%999,132
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARRY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARRY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Redmile Group, LLC10% Owner 2016-01-20Buy300,000$3.19-20.06view
Redmile Group, LLC10% Owner 2016-01-12Buy75,000$3.6-29.17view
Redmile Group, LLC10% Owner 2016-01-11Buy925,000$3.67-30.52view
Redmile Group, LLC10% Owner 2015-10-01Buy782,592$4.58-44.32view
Redmile Group, LLC10% Owner 2015-10-01Buy600,140$4.58-44.32view
Redmile Group, LLC10% Owner 2015-08-26Buy49,900$5.48-53.47view
Redmile Group, LLC10% Owner 2015-08-25Buy790,000$5.38-52.6view
Redmile Group, LLC10% Owner 2015-08-12Buy532,500$5.88-56.63view
Redmile Group, LLC10% Owner 2015-08-10Buy1,048,993$5.8-56.03view
BAUM CHARLES MDirector 2015-05-08Sell25,000$7.38-65.45view

Quarterly/Annual Reports about ARRY:

News about ARRY:

Articles On GuruFocus.com
Screen: Stocks With Estimated Revenue Up 5% - January Jan 18 2016 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
Novartis Gets FTC Nod To Buyout Glaxo Smithkline’s Cancer Drugs Feb 25 2015 
Can These Three BioTech Companies Make It Big? Feb 20 2015 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,310 Shares Mar 16 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,403 Shares Feb 11 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,272 Shares Jan 13 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,256 Shares Dec 10 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,220 Shares Nov 12 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,225 Shares Oct 13 2010 

More From Other Websites
ARRAY BIOPHARMA INC Financials Feb 11 2016
Biotechnology Stocks Technical Review -- MannKind, Array BioPharma, Arena Pharma, and Chimerix Feb 08 2016
ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report Feb 05 2016
Edited Transcript of ARRY earnings conference call or presentation 2-Feb-16 2:00pm GMT Feb 02 2016
Array BioPharma To Present At The Leerink Partners Annual Global Healthcare Conference Feb 02 2016
Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today Feb 02 2016
Array BioPharma reports 2Q loss Feb 02 2016
Array BioPharma reports 2Q loss Feb 02 2016
Q2 2016 Array Biopharma Inc Earnings Release - Before Market Open Feb 02 2016
ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 02 2016
Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2016 Feb 02 2016
Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with... Feb 01 2016
Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with... Feb 01 2016
Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2016 On February 2,... Jan 26 2016
Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2016 On February 2,... Jan 26 2016
5 Stocks Insiders Love Right Now Jan 13 2016
Buffett, Starboard Among the Elite Investors to Disclose New Moves Jan 12 2016
QIAGEN Reaches Milestone With Portfolio of Master Collaboration Agreements for Pharma Companion... Jan 11 2016
Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference Jan 06 2016
Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference Jan 06 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK